Article

Heidelberg Engineering VP discusses HRT work

Vista, CA-John Hawley, vice president of Heidelberg Engineering, served as an expert panelist at the Life Sciences Industry Council program, "Innovations in Eye Disease Technology," in Irvine, CA.

Related Videos
EyeCon 2024: Adam Wenick, MD, talks about myopic interventions across the lifespan
Adam Wenick, MD, chairs EyeCon session: New treatments in geographic atrophy from detection to intervention
EyeCon 2024: Laura M. Periman, MD, shares her passion for dry eye disease, discussing her surprising discovery of the Alpenglow Sign in Demodex blepharitis
David Eichenbaum, MD, presents advances in AMD therapy, highlights different mechanisms with a common goal
Cochair Kelly K. Nichols, OD, PhD, MPH, FAAO, highlights her passion for dry eye research and the vital collaboration between ophthalmology and optometry
EyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future
Promising results for faricimab revealed in TENAYA, LUCERNE year 2 data
Related Content
Tapping metabolomics for timely detection of glaucoma cases
September 11th 2024

Tapping metabolomics for timely detection of glaucoma cases

Ehsan Sadri, MD, and Colin Green, PhD: How a noninvasive eye drop therapy could transform keratoconus care
September 23rd 2024

Innovation Series: What a noninvasive eye drop approach may mean for the future of keratoconus

What ophthalmologists need to know about neuromyelitis optica spectrum disorder
July 24th 2024

What ophthalmologists need to know about neuromyelitis optica spectrum disorder

Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics
August 30th 2024

Latest advances in X-linked retinitis pigmentosa: Optimizing diagnosis and developments in gene therapy

FDA approves faricimab-svoa 6.0 mg single-dose prefilled syringe for use in the treatment of wet AMD, DME and RVO
July 5th 2024

FDA approves faricimab-svoa 6.0 mg single-dose prefilled syringe for use in the treatment of wet AMD, DME and RVO

Pearls for the treatment of patients with neurotrophic keratitis
June 21st 2024

Pearls for the treatment of patients with neurotrophic keratitis

© 2024 MJH Life Sciences

All rights reserved.